• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸作为恶性疟原虫组蛋白去乙酰化酶1(PfHDAC1)的潜在抑制剂:一种计算机模拟方法。

Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): an in silico approach.

作者信息

Elbadawi Mohamed A Abdallah, Awadalla Mohamed Khalid Alhaj, Hamid Muzamil Mahdi Abdel, Mohamed Magdi Awadalla, Awad Talal Ahmed

机构信息

Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum 11111, Sudan.

College of Pharmacy, University of Hail, Hail 81451, Saudi Arabia.

出版信息

Int J Mol Sci. 2015 Feb 11;16(2):3915-31. doi: 10.3390/ijms16023915.

DOI:10.3390/ijms16023915
PMID:25679451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4346934/
Abstract

A new Plasmodium falciparum histone deacetylase1 (PfHDAC1) homology model was built based on the highest sequence identity available template human histone deacetylase 2 structure. The generated model was carefully evaluated for stereochemical accuracy, folding correctness and overall structure quality. All evaluations were acceptable and consistent. Docking a group of hydroxamic acid histone deacetylase inhibitors and valproic acid has shown binding poses that agree well with inhibitor-bound histone deacetylase-solved structural interactions. Docking affinity dG scores were in agreement with available experimental binding affinities. Further, enzyme-ligand complex stability and reliability were investigated by running 5-nanosecond molecular dynamics simulations. Thorough analysis of the simulation trajectories has shown that enzyme-ligand complexes were stable during the simulation period. Interestingly, the calculated theoretical binding energies of the docked hydroxamic acid inhibitors have shown that the model can discriminate between strong and weaker inhibitors and agrees well with the experimental affinities reported in the literature. The model and the docking methodology can be used in screening virtual libraries for PfHDAC1 inhibitors, since the docking scores have ranked ligands in accordance with experimental binding affinities. Valproic acid calculated theoretical binding energy suggests that it may inhibit PfHDAC1.

摘要

基于序列同源性最高的模板人类组蛋白去乙酰化酶2的结构,构建了一种新的恶性疟原虫组蛋白去乙酰化酶1(PfHDAC1)同源模型。对生成的模型进行了仔细评估,包括立体化学准确性、折叠正确性和整体结构质量。所有评估结果均可接受且一致。对接一组异羟肟酸组蛋白去乙酰化酶抑制剂和丙戊酸,所显示的结合构象与抑制剂结合的组蛋白去乙酰化酶解析结构相互作用非常吻合。对接亲和力dG分数与现有的实验结合亲和力一致。此外,通过运行5纳秒的分子动力学模拟研究了酶-配体复合物的稳定性和可靠性。对模拟轨迹的深入分析表明,酶-配体复合物在模拟期间是稳定的。有趣的是,对接的异羟肟酸抑制剂的计算理论结合能表明,该模型能够区分强抑制剂和弱抑制剂,并且与文献报道的实验亲和力非常吻合。该模型和对接方法可用于筛选PfHDAC1抑制剂的虚拟文库,因为对接分数已根据实验结合亲和力对配体进行了排序。丙戊酸的计算理论结合能表明它可能抑制PfHDAC1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/4f0c2950a71c/ijms-16-03915-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/e1a78117eaa8/ijms-16-03915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/85d36290d3c1/ijms-16-03915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/3e5a2e64a2d3/ijms-16-03915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/66db224bf11e/ijms-16-03915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/9866ac1cc820/ijms-16-03915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/37ab886a9c0b/ijms-16-03915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/40e21394015b/ijms-16-03915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/a0ce98a72b9d/ijms-16-03915-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/4f0c2950a71c/ijms-16-03915-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/e1a78117eaa8/ijms-16-03915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/85d36290d3c1/ijms-16-03915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/3e5a2e64a2d3/ijms-16-03915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/66db224bf11e/ijms-16-03915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/9866ac1cc820/ijms-16-03915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/37ab886a9c0b/ijms-16-03915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/40e21394015b/ijms-16-03915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/a0ce98a72b9d/ijms-16-03915-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81af/4346934/4f0c2950a71c/ijms-16-03915-g009.jpg

相似文献

1
Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): an in silico approach.丙戊酸作为恶性疟原虫组蛋白去乙酰化酶1(PfHDAC1)的潜在抑制剂:一种计算机模拟方法。
Int J Mol Sci. 2015 Feb 11;16(2):3915-31. doi: 10.3390/ijms16023915.
2
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.含肉桂酸或 NSAID 成分的抗疟组蛋白去乙酰化酶抑制剂。
Bioorg Med Chem Lett. 2010 Dec 1;20(23):7080-4. doi: 10.1016/j.bmcl.2010.09.096. Epub 2010 Sep 22.
3
In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).恶性疟原虫组蛋白去乙酰化酶1(PfHDAC-1)抑制剂的计算机模拟鉴定
J Mol Model. 2018 Aug 14;24(9):232. doi: 10.1007/s00894-018-3761-1.
4
In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.基于 1,2,3-三唑键的新型查尔酮和黄酮杂合衍生物作为恶性疟原虫二氢乳清酸脱氢酶关键抑制剂的计算机分子对接和模拟研究。
J Biomol Struct Dyn. 2018 Nov;36(15):3993-4009. doi: 10.1080/07391102.2017.1404935. Epub 2017 Nov 27.
5
Fragment-Based Drug Design of Selective HDAC6 Inhibitors.选择性组蛋白去乙酰化酶6(HDAC6)抑制剂的基于片段的药物设计
Methods Mol Biol. 2021;2266:155-170. doi: 10.1007/978-1-0716-1209-5_9.
6
Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins.恶性疟原虫组蛋白去乙酰化酶1复合蛋白的蛋白质组学分析。
Exp Parasitol. 2019 Mar;198:7-16. doi: 10.1016/j.exppara.2019.01.008. Epub 2019 Jan 22.
7
Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach.采用 MMGBSA 方法探索丙戊酸对组蛋白去乙酰化酶家族的抑制活性。
J Comput Aided Mol Des. 2020 Aug;34(8):857-878. doi: 10.1007/s10822-020-00304-2. Epub 2020 Mar 16.
8
Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.疟原虫转酮醇酶的表征及潜在抑制剂的鉴定:一项计算机模拟研究
Malar J. 2020 Nov 30;19(1):442. doi: 10.1186/s12936-020-03512-1.
9
Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.基于异羟肟酸的选择性HDAC1抑制剂的鉴定:计算机辅助药物设计研究
Curr Comput Aided Drug Des. 2019;15(2):145-166. doi: 10.2174/1573409914666180502113135.
10
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.发现对疟原虫多个生命周期阶段具有强效活性的组蛋白去乙酰化酶(HDAC)抑制剂。
Eur J Med Chem. 2014 Jul 23;82:204-13. doi: 10.1016/j.ejmech.2014.05.050. Epub 2014 May 22.

引用本文的文献

1
Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites.基于戊氧基酰胺的组蛋白去乙酰化酶抑制剂对恶性疟原虫的抗疟活性。
Int J Parasitol Drugs Drug Resist. 2025 Aug 16;29:100608. doi: 10.1016/j.ijpddr.2025.100608.
2
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors.重新利用美国食品药品监督管理局(FDA)批准的药物治疗足菌肿:CYP51抑制剂的同源建模与计算筛选
Int J Mol Sci. 2025 Jan 1;26(1):315. doi: 10.3390/ijms26010315.
3
PfHDAC1 is an essential regulator of asexual proliferation and host cell invasion genes with a dynamic genomic occupancy responsive to artemisinin stress.

本文引用的文献

1
MMFF VI. MMFF94s option for energy minimization studies.MMFF VI。用于能量最小化研究的MMFF94s选项。
J Comput Chem. 1999 May;20(7):720-729. doi: 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X.
2
Spread of artemisinin resistance in Plasmodium falciparum malaria.疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
3
Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders.在科妮莉亚·德朗热综合征谱系障碍中鉴定出的HDAC8突变体的结构和功能受损。
PfHDAC1 是无性繁殖和宿主细胞入侵基因的必需调节因子,其基因组占据具有动态性,可响应青蒿素压力。
mBio. 2024 Jun 12;15(6):e0237723. doi: 10.1128/mbio.02377-23. Epub 2024 May 6.
4
Protein acetylation in the critical biological processes in protozoan parasites.原虫寄生虫中关键生物过程的蛋白质乙酰化。
Trends Parasitol. 2021 Sep;37(9):815-830. doi: 10.1016/j.pt.2021.04.008. Epub 2021 May 12.
5
A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1.一种靶向恶性疟原虫组蛋白去乙酰化酶1的新型多阶段抗疟原虫抑制剂。
Cell Discov. 2020 Dec 11;6(1):93. doi: 10.1038/s41421-020-00215-4.
6
In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).恶性疟原虫组蛋白去乙酰化酶1(PfHDAC-1)抑制剂的计算机模拟鉴定
J Mol Model. 2018 Aug 14;24(9):232. doi: 10.1007/s00894-018-3761-1.
7
The Effect of VPA on Increasing Radiosensitivity in Osteosarcoma Cells and Primary-Culture Cells from Chemical Carcinogen-Induced Breast Cancer in Rats.丙戊酸对提高骨肉瘤细胞及大鼠化学致癌物诱导乳腺癌原代培养细胞放射敏感性的影响
Int J Mol Sci. 2017 May 10;18(5):1027. doi: 10.3390/ijms18051027.
ACS Chem Biol. 2014 Sep 19;9(9):2157-64. doi: 10.1021/cb5003762. Epub 2014 Jul 30.
4
Inhibition and mechanism of HDAC8 revisited.HDAC8的抑制作用及其机制再探讨。
J Am Chem Soc. 2014 Aug 20;136(33):11636-43. doi: 10.1021/ja501548p. Epub 2014 Aug 7.
5
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.丙戊酸联合全反式维 A 酸和强化治疗用于老年急性髓系白血病患者。
Blood. 2014 Jun 26;123(26):4027-36. doi: 10.1182/blood-2013-12-546283. Epub 2014 May 5.
6
Integrated computational tools for identification of CCR5 antagonists as potential HIV-1 entry inhibitors: homology modeling, virtual screening, molecular dynamics simulations and 3D QSAR analysis.用于鉴定CCR5拮抗剂作为潜在HIV-1进入抑制剂的综合计算工具:同源建模、虚拟筛选、分子动力学模拟和3D QSAR分析。
Molecules. 2014 Apr 23;19(4):5243-65. doi: 10.3390/molecules19045243.
7
Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers.晚期癌症患者中抗血管内皮生长因子单克隆抗体贝伐珠单抗和组蛋白去乙酰化酶抑制剂丙戊酸的 I 期研究。
Cancer Chemother Pharmacol. 2014 Mar;73(3):495-501. doi: 10.1007/s00280-014-2384-1. Epub 2014 Jan 17.
8
Activities at the Universal Protein Resource (UniProt).通用蛋白质资源库(UniProt)的活动。
Nucleic Acids Res. 2014 Jan;42(Database issue):D191-8. doi: 10.1093/nar/gkt1140. Epub 2013 Nov 18.
9
Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni.组蛋白去乙酰化酶 8(HDAC8)抑制的结构基础,HDAC8 是曼氏血吸虫中的一个关键表观遗传因子。
PLoS Pathog. 2013;9(9):e1003645. doi: 10.1371/journal.ppat.1003645. Epub 2013 Sep 26.
10
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.组蛋白去乙酰化酶(HDAC)抑制剂的动力学速率常数与细胞组蛋白乙酰化相关,但与转录和细胞活力无关。
J Biol Chem. 2013 Sep 13;288(37):26926-43. doi: 10.1074/jbc.M113.490706. Epub 2013 Jul 29.